为支持未来分析而开发的多发性骨髓瘤健康经济模型的系统文献综述

多发性骨髓瘤健康经济模型与卫生技术经济评价的系统文献综述,最终纳入49篇文献并总结研究缺口。

NIAID Data Ecosystem
浏览 9
文本Multiple myelomadirect costsindirect coststreatment costseconomic burdenhealth economic modellingliterature reviewI19I1II10
Systematic literature review of health economic models developed for multiple myeloma to support future analyses

基本信息

模态
文本
大小
0.000097856 GB
许可
CC BY 4.0
创建/更新时间
2026-10-17
版本
v2

资源简介

为支持未来分析而开发的多发性骨髓瘤健康经济模型的系统文献综述

【一句话概览】

本数据集是 figshare 公开的文本数据集,收录 5 个文件、合计 97.86 KB,主题涵盖 Multiple myeloma、direct costs、indirect costs、treatment costs、economic burden,可用于医学自然语言处理(实体识别、信息抽取等),CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Systematic literature review of health economic models developed for multiple myeloma to support future analyses》。配套论文《Systematic literature review of health economic models developed for multiple myeloma to support future analyses》发表于 Journal of Medical Economics(2023),DOI:10.1080/13696998.2022.2144056。项目资助方:Funding for this study was provided by the International Myeloma Foundation (IMF).。源站首次发布:2023-01-09。

【数据内容】

源站原始描述:The goal of this study was to review the economic evaluations of health technologies in multiple myeloma (MM) and provide guidance and recommendations for future health economic analyses. A systemic literature review (SLR) was conducted on original economic assessment studies and structured review papers focusing on the studies in MM. The search was limited to English language papers published from 1 January 2000 onwards. Publications not applying any type of modelling methodology to describe di…

【数据结构与技术规格】

文件数 5 个,合计 97.86 KB。ijme_a_2144056_sm3073.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,15.45 KB。ijme_a_2144056_sm3071.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,17.82 KB。ijme_a_2144056_sm2900.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,17.89 KB。数据集 DOI:10.6084/m9.figshare.21517412.v2。

【主题与分类】

源站学科分类:Medicine、Biotechnology、Environmental Sciences not elsewhere classified、Biological Sciences not elsewhere classified、Cancer、Science Policy。主题标签:Multiple myeloma、direct costs、indirect costs、treatment costs、economic burden、health economic modelling、literature review、I19、I1、I。

【适用方向】

文本类数据可用于医学自然语言处理,如命名实体识别、信息抽取与文本分类。

【获取与许可】

源站页面:https://tandf.figshare.com/articles/dataset/Systematic_literature_review_of_health_economic_models_developed_for_multiple_myeloma_to_support_future_analyses/21517412

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Systematic literature review of health economic models developed for multiple myeloma to support future analyses. Taylor & Francis. Choon-Quinones, Mimi; Zelei, Tamás; Németh, Bertalan; Tóth, Manna; Jia, Xiao Yang; Barnett, Mike; et al

【使用注意】

· 源站最后修改于 2024-03-21,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "ijme_a_2144056_sm3073.docx" "https://ndownloader.figshare.com/files/38765751"
curl -L -o "ijme_a_2144056_sm3071.docx" "https://ndownloader.figshare.com/files/38765754"
curl -L -o "ijme_a_2144056_sm2900.docx" "https://ndownloader.figshare.com/files/38765757"
curl -L -o "ijme_a_2144056_sm2895.docx" "https://ndownloader.figshare.com/files/38765760"
curl -L -o "ijme_a_2144056_sm2891.docx" "https://ndownloader.figshare.com/files/38765763"

文件清单

  • ijme_a_2144056_sm3073.docx(15.45 KB)
  • ijme_a_2144056_sm3071.docx(17.82 KB)
  • ijme_a_2144056_sm2900.docx(17.89 KB)
  • ijme_a_2144056_sm2895.docx(18.32 KB)
  • ijme_a_2144056_sm2891.docx(28.38 KB)

文件总体积 97.86 KB(源站 API 实测)。

数据说明

The goal of this study was to review the economic evaluations of health technologies in multiple myeloma (MM) and provide guidance and recommendations for future health economic analyses.
A systemic literature review (SLR) was conducted on original economic assessment studies and structured review papers focusing on the studies in MM. The search was limited to English language papers published from 1 January 2000 onwards. Publications not applying any type of modelling methodology to describe disease progression and patient pathways over a specific time horizon were excluded.
A total of 2,643 publications were initially identified, of which 148 were eligible to be included in the full-text review phase. From these, 49 publications were included in the final analysis. Most published health economic analyses supported by models came from high-income countries. Evaluations from middle-income countries were rarely published. Diagnostic technologies were rarely modelled and integrated care had not been modelled. Very few models investigated MM treatments from a societal perspective and there was a relative lack of evaluations regarding minimal residual disease (MRD).
Limitations of the publications included differences between trial populations and modelled populations, justification of methods, lack of confounder analyses, and small trial populations. Limitations of our study included the infeasibility of comparing MM economic evaluations due to the significant variance in modelled therapeutic lines and indications, and the relative scarcity of published economic evaluations from non-high-income countries.
As published economic models lacked many of the elements of the complex and heterogeneous patient pathways in MM and they focused on single decision problems, a thorough, open-source economic whole disease modelling framework is needed to assess the economic value of a wide range of technologies across countries with various income levels with a more detailed view on MM, by including patient-centric and societal aspects.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.21517412.v2(source: https://tandf.figshare.com/articles/dataset/Systematic_literature_review_of_health_economic_models_developed_for_multiple_myeloma_to_support_future_analyses/21517412)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案